UK Markets closed

Global Pharmacovigilance and Drug Safety Software Market 2021-2027: Rising Incidences Of Adverse Drug Reactions (ADRs) & Globalization Of Pharmacovigilance Driving Growth

Research and Markets
·5-min read

Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Pharmacovigilance and Drug Safety Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Software Type; Delivery Mode; and End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

Adverse Event Reporting Software Segment to Grow at Highest CAGR During 2020-2027

Pharmacovigilance and Drug Safety Software Market is expected to reach US$ 292.97 Mn in 2027 from US$ 160.67 Mn in 2019. The market is estimated to grow at a CAGR of 7.6% from 2020 to 2027.

The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance have been boosting the market over the years. However, the expensive technology is likely to have a negative impact on the growth of the market in the coming years.

By software. However, the fully integrated software segment is anticipated to grow at the highest rate during the forecast period owing to its accuracy to avoid data redundancy by eliminating errors and tracking individual case safety reports

AB Cube, United BioSource LLC, ARISGLOBAL LLC, Sparta Systems, Inc., Oracle Corporation, Sarjen Systems Pvt. Ltd., EXTEDO, ENNOV, Max Application and Anju Software, Inc. are among the leading companies operating in the pharmacovigilance and drug safety software market. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the pharmacovigilance and drug safety software.

For instance, in Aug 2019, Veeva Systems unveiled Veeva Vault Safety.AI, a new artificial intelligence technology that automates case intake in order to reduce the time and effort spent on manual data entry. To complement Vault Safety and Vault SafetyDocs, Veeva provides the first integrated suite of cloud applications on a shared platform to control the end-to-end drug safety lifecycle.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmacovigilance and drug safety software market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmacovigilance and drug safety software market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation

2. Global Pharmacovigilance (PV) and Drug Safety Software Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Pharmacovigilance (PV) and Drug Safety Software Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions

5. Global Pharmacovigilance (PV) and Drug Safety Software Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences Of Adverse Drug Reactions (ADRs)
5.1.2 Globalization Of Pharmacovigilance
5.2 Key Market Restraints
5.2.1 Expensive Technology
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence In Pharmacovigilance
5.5 Impact Analysis

6. Pharmacovigilance (PV) and Drug Safety Software Market - Global Analysis
6.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis
6.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players

7. Global Pharmacovigilance (PV) And Drug Safety Software Analysis- by Software Type
7.1 Overview
7.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2019 & 2027 (%)
7.3 Adverse Event Reporting Software Market
7.4 Drug Safety Audits Software
7.5 Issue Tracking Software
7.6 Fully Integrated Software

8. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis- by Delivery Mode
8.1 Overview
8.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)
8.3 On-premise Market
8.4 Cloud- Based Market

9. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis- by End User
9.1 Overview
9.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By End User 2019 & 2027 (%)
9.3 Pharmaceutical and Biotech Companies Market
9.4 Contract Research Organizations (CROs) Market
9.5 Business Process Outsourcing (BPO) Firms Market

10. Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 - Geographical Analysis

11. Pharmacovigilance (PV) and Drug Safety Software Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
11.3 Organic Developments
11.4 Inorganic Developments

12. Pharmacovigilance (PV) and Drug Safety Software Market-Key Company Profiles
12.1 Key Facts
12.2 Business Description
12.3 Products and Services
12.4 Financial Overview
12.5 SWOT Analysis
12.6 Key Developments

  • Veeva Systems

  • IQVIA Inc.

  • Ennov

  • AB Cube

  • United Biosource LLC

  • ArisGlobal LLC

  • Sparta Systems

  • Oracle Corporation

  • Sarjen Systems Pvt. Ltd

  • EXTEDO

  • Maxapplication

  • Online Business Applications, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/affdj2

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900